Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00930579 · ClinicalTrials.gov registry record · Phase 2
Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation
A Phase 2 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT00930579 is a Phase 2 study that has completed, run by Columbia University. The registered enrollment target is 35 participants.
The verdict
NCT00930579, a Phase 2 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to use a pre surgical intervention model to evaluate the biologic effects of metformin in women with newly diagnosed early invasive breast cancer. Metformin is a drug commonly used to treat patients with diabetes. This model will be used to evaluate the effects of metformin.
Interventions
- DRUG Metformin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2009-10-16 |
| Est. Completion | 2017-01-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00930579
The ClinicalTrials.gov registry entry for NCT00930579 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metformin is the first listed.
NCT00930579 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00930579 about?
NCT00930579 is a clinical study titled "Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation". The purpose of this pilot study is to use a pre surgical intervention model to evaluate the biologic effects of metformin in women with newly diagnosed early invasive breast cancer. Metformin is a drug commonly used to treat patients with diabetes. This model will be used to evaluate the effects of ...
What is the current status of trial NCT00930579?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2009-10-16. Estimated completion is 2017-01-09.
What interventions are being tested in trial NCT00930579?
The interventions under investigation include: Metformin (DRUG).
Who is sponsoring clinical trial NCT00930579?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.